USC Roski Eye Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Graves' disease and hyperthyroidism2 trials
• Retinitis pigmentosa1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Viridian Therapeutics, Inc.2 trials
• Jaeb Center for Health Research1 trial

Running trials

• Recruiting

  Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

  NCT05589714· Jaeb Center for Health Research· Source

  Contact: Hossein Ameri, MD, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Retinitis pigmentosa1 recruiting

Closed trials

• Completed

  An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

  NCT06021054· Phase 3· Viridian Therapeutics, Inc.· Source

• Completed

  A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

  NCT05176639· Phase 3· Viridian Therapeutics, Inc.· Source